[
  {
    "ts": "2026-02-11T05:01:02+00:00",
    "headline": "Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst ...",
    "summary": "Edwards Lifesciences Corp (EW) reports robust Q4 2025 results with an 11.6% sales increase, while navigating challenges in EPS and strategic spending.",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-corp-ew-q4-050102695.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "a2425bac-749c-3f16-92ee-9a0d9552c0c4",
      "content": {
        "id": "a2425bac-749c-3f16-92ee-9a0d9552c0c4",
        "contentType": "STORY",
        "title": "Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst ...",
        "description": "",
        "summary": "Edwards Lifesciences Corp (EW) reports robust Q4 2025 results with an 11.6% sales increase, while navigating challenges in EPS and strategic spending.",
        "pubDate": "2026-02-11T05:01:02Z",
        "displayTime": "2026-02-11T05:01:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-corp-ew-q4-050102695.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-corp-ew-q4-050102695.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T03:07:18+00:00",
    "headline": "Edwards Lifesciences Q4 Earnings Call Highlights",
    "summary": "Edwards Lifesciences (NYSE:EW) reported fourth-quarter and full-year 2025 results that management characterized as strong, driven by continued momentum in transcatheter aortic valve replacement (TAVR) and rapid growth in transcatheter mitral and tricuspid therapies (TMTT). The company said fourth-qu",
    "url": "https://www.marketbeat.com/instant-alerts/edwards-lifesciences-q4-earnings-call-highlights-2026-02-10/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "5c10140c-8c75-3965-bf92-2a9c75468335",
      "content": {
        "id": "5c10140c-8c75-3965-bf92-2a9c75468335",
        "contentType": "STORY",
        "title": "Edwards Lifesciences Q4 Earnings Call Highlights",
        "description": "",
        "summary": "Edwards Lifesciences (NYSE:EW) reported fourth-quarter and full-year 2025 results that management characterized as strong, driven by continued momentum in transcatheter aortic valve replacement (TAVR) and rapid growth in transcatheter mitral and tricuspid therapies (TMTT). The company said fourth-qu",
        "pubDate": "2026-02-11T03:07:18Z",
        "displayTime": "2026-02-11T03:07:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/7f35491c86968056c1ecaa0b8bd4e9ee",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Edwards Lifesciences logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2rYmEG.6Xu.y6vvx0ynVoA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/7f35491c86968056c1ecaa0b8bd4e9ee.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Xs8PRxmFhPHZk3e5PF26Ng--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/7f35491c86968056c1ecaa0b8bd4e9ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/edwards-lifesciences-q4-earnings-call-highlights-2026-02-10/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-q4-earnings-call-030718626.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]